Paychex, Inc. (Nasdaq: PAYX) (the "Company," "Paychex," "we," "our," or "us"), an industry-leading human capital management ( ...

Successfully dosed first three cohorts in SAD portion of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data ...

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life ...

It has been about a month since the last earnings report for ProAssurance (PRA). Shares have added about 0.9% in that time frame, outperforming the S&P 500. But investors have to be wondering, will ...

TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter ...

Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. -- Selling, general and administrative ("SG&A") expenses were $241.5 million for ...

It has been about a month since the last earnings report for Viper Energy Partners (VNOM). Shares have added about 5% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

Skyrocketing infrastructure costs and an increasingly capital-intensive business model are putting intense pressure on the ...

Reports Revenue of $5.6 Million - Posting fourth consecutive quarter of growth and highest recorded annual revenue in the Company's history -- Lowest Quarterly Net Loss since 2013 - Evidencing further ...

Form 52 replaces Form 3CEF and mandates annual APA compliance reporting. It introduces structured disclosures and ensures ...

TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ...

Fourth quarter 2025 total revenue of $7.3 million at the top of the range of previous preliminary announcement ...